Search Results

SLV-2436 25 mg  | 99.85%

TargetMol

SLV-2436 (SEL201-88) is a novel effective and ATP-competitive inhibitor of MNK1 and MNK2 (IC50: 10.8/5.4 nM).

More Information Supplier Page

SLV-2436 10 mg  | 99.85%

TargetMol

SLV-2436 (SEL201-88) is a novel effective and ATP-competitive inhibitor of MNK1 and MNK2 (IC50: 10.8/5.4 nM).

More Information Supplier Page

Lificiguat 100 mg  | 99.48%

TargetMol

YC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).

More Information Supplier Page

Lificiguat 50 mg  | 99.48%

TargetMol

YC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).

More Information Supplier Page

Lificiguat 25 mg  | 99.48%

TargetMol

YC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).

More Information Supplier Page

Lificiguat 10 mg  | 99.48%

TargetMol

YC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).

More Information Supplier Page

Lificiguat 5 mg  | 99.48%

TargetMol

YC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).

More Information Supplier Page